Switzerland Agrees on Six Healthcare Cost-Containment Measures

On October 26, 2026, the Swiss Federal Department of Home Affairs (EDI) convened the 5th Round Table on Cost Containment, bringing together representatives from the Federal Office of Public Health (FOPH), the Swiss Conference of Cantonal Health Directors (GDK), the Swiss Medical Association (FMH), H+, prio.swiss and other healthcare stakeholders.

The meeting resulted in six structural measures aimed at containing healthcare expenditure and improving healthcare efficiency. Implementation is expected to begin in 2027, subject to agreement between tariff partners, technical adjustments and Federal Council approval.

Promotion of outpatient care. The measures aim to shift elective procedures with significant potential for outpatient substitution from inpatient to outpatient settings. OAAT AG and SwissDRG AG will establish a binding list of eligible clinical cases. During a transitional period of up to five years, outpatient flat rates may be calculated using a broader dataset combining ambulatory data with cost-adjusted inpatient data. Tariff proposals are expected to be submitted to the Federal Council by January 2028, or no later than January 2029.

Increased medical device pricing transparency. Electronic invoices for medical devices billed separately from outpatient flat-rate tariffs will be required to include the Unique Device Identification – Device Identifier (UDI-DI). This will enable health insurers to automate price benchmarking and reject prices deemed uneconomical. The price data collected will also be shared with OAAT AG to support the refinement and further development of outpatient flat-rate tariffs.

Introduction of disease management programs for chronic conditions. The package seeks to expand structured disease management programs supported by software integrated into clinical workflows and supervised by physicians. An outpatient tariff for remote monitoring of patients with heart failure is scheduled to take effect on 1 January 2027, subject to Federal Council approval. Further programs are envisaged for chronic obstructive pulmonary disease (COPD) and inflammatory bowel disease (IBD), with diabetes also identified as a priority.

Promotion of home-based therapies. The measures aim to increase self-administration of treatments for chronic conditions, including medicines delivered through pre-filled pens, syringes and pumps. Medical societies will develop a positive list of therapies suitable for home administration.

Reduction of pressure on hospital emergency departments. The package promotes digital patient guidance, self-assessment and telemedical triage to prevent avoidable emergency department visits. According to the Round Table, systematic use of digital self-assessment or telemedical consultations before emergency visits could generate annual savings of more than CHF 320 million in compulsory health insurance costs.

Coordinated medication supply in long-term care. The final measure focuses on improving coordination of medication supply in long-term care facilities to increase efficiency and reduce expenditure.

What does it mean for the industry?

The measures combine changes to care delivery, reimbursement structures, pricing transparency, and digital healthcare. For medical device manufacturers, the most direct implication is the planned introduction of UDI-DI requirements for devices billed separately from outpatient flat-rate tariffs, enabling more systematic price benchmarking by insurers.

Manufacturers should check whether their products fall within the scope of the new invoicing requirements, assess their readiness to provide UDI-DI information and evaluate potential implications for pricing and reimbursement. Companies active in outpatient procedures, remote monitoring and home-based therapies should also assess the relevance of the evolving care pathways and tariff arrangements to their products. The practical impact will depend on the detailed implementation of the measures.

This news is just one of about 300 market access news and updates collected by our team in the premium subscription service MTRC Access Intelligence every week from more than 80 organizations. Access our paid service to stay on top of all developments, specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, six-week, no-obligation trial.